Document is current
Any future updates will be listed below
-
Authors
Udovica, Simon
Bartsch, Rupert
Singer, Christian F.
Leitgeb, Clemens
Marhold, Maximilian
Peters-Engl, Christian
Sagaster, Verena
Hochmair, Maximilian
Ferner, Muna
Hilbe, Wolfgang
Strasser-Weippl, Kathrin
- License Information
-
More Information
Article History
Received: 27 March 2025
Accepted: 13 March 2026
First Online: 17 April 2026
Competing interests
: Simon Udovica: Advisory Role: Johnson & Johnson, Amgen; Oncopeptides. Lecture Honoraria: Novartis, Servier, Eli-Lilly, MedMedia; Travel support: AbbVie, AOP-Orphan, Beigene, GlaxoSmithKline, Janssen, Eli-Lilly, Pfizer, Roche, Servier, Stemline. Rupert Bartsch: Advisory Role: Astra-Zeneca, Daiichi, Eisai, Eli-Lilly, Gilead, Gruenenthal, MSD, Novartis, Pfizer, Pierre-Fabre, Roche, Seagen, Stemline; Lecture Honoraria: Amgen, Astra-Zeneca, BMS, Daichi, Eisai, Eli-Lilly, Gilead, Gruenenthal, MSD, MedMedia, Novartis, Pfizer, Pierre-Fabre, Roche, Seagen, Stemline; Research Support: Daiichi. Christian F. Singer: Research, educational, and travel grants from Novartis, AstraZeneca, Daiichi-Sankyo and Gilead. Maximilian Marhold: Lectures, advisory board participation and consultation: Roche, Eli Lilly, Novartis, AstraZeneca, Daiichi Sankyo, Pfizer, MSD, Gilead and Medmedia. Travel support: Amgen, Gilead, Roche, Novartis, Pierre Fabre, Daiichi Sankyo and Eisai.Verena Sagaster: Advisory Role: Eli Lilly, Novartis, Pfizer. Consultant and Speaker Roles: Eli Lilly, AstraZeneca, Roche, Novartis, Pfizer, Gilead. Maximilian Hochmair: Advisory, Consultant and Speaker Roles: Roche, BMS, MSD, Lilly, Amgen, Takeda. Muna Ferner: Travel support: Roche, Pfizer, Daiichi Sankyo, Novartis. Speaker Roles: MSD. Kathrin Strasser-Weippl: Advisory Boards: Roche, Pfizer, Novartis, Lilly, Daiichi, Myriad, Seagen, MSD, AstraZeneca. Travel support: Roche, Pfizer, MSD.
